Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-22-113070
Filing Date
2022-04-21
Accepted
2022-04-21 16:27:07
Documents
16
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d309817d10ka.htm   iXBRL 10-K/A 185780
2 EX-31.1 d309817dex311.htm EX-31.1 3441
3 EX-31.2 d309817dex312.htm EX-31.2 3454
  Complete submission text file 0001193125-22-113070.txt   429268

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20211231.xsd EX-101.SCH 4925
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ffntf-20211231_cal.xml EX-101.CAL 686
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ffntf-20211231_def.xml EX-101.DEF 19255
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20211231_lab.xml EX-101.LAB 25660
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20211231_pre.xml EX-101.PRE 20612
10 EXTRACTED XBRL INSTANCE DOCUMENT d309817d10ka_htm.xml XML 7491
Mailing Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3
Business Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3 (602) 682-7037
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-56075 | Film No.: 22841776
SIC: 2833 Medicinal Chemicals & Botanical Products